GLP-1 analogues have become a clinician's best friend as they are able to maintain glycemic control and decrease hypoglycemia and the other risks as well as promote weight loss
Adverse events are usually limited to injection-site reactions: transient soreness, redness, occasional bruising
Ask for peer-reviewed data, not just testimonials or month-one before-and-afters
334 To explore its potential in high-risk populations, the ongoing KARDIA-3 trial (NCT06272487) is enrolling cardiovascular high-risk patients or those with advanced chronic kidney disease who are taking 24 antihypertensive agents
Cost comparisons reveal $2,000-$3,200 for an 8-week IV course versus $70-$340 for oral and topical combination therapy
Materials and methods Bioinformatics methodology for polybia-MP1 characterization To characterize Polybia-MP1, a series of bioinformatics analyses were conducted